Company
Eldec Pharmaceuticals
Novel peptide therapeutics for chronic lung diseases
Also known as ELDEC PHARMACEUTICALS, INC.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- ELDEC PHARMACEUTICALS, INC.
Claim, correct or request removal
Record updated 28 September 2026
About
Eldec has discovered naturally-occurring peptides in the lung which inhibit inflammation, tissue remodeling and fibrosis. These peptides are further optimized to increase potency and make them better drug candidates.
Funding snapshot
- Total raised
- $200KSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $200K2026-02-11
Funding rounds
- Round, 2026
- $200K2026-02-11, SEC form D sold, 1 investor
Loading relationship preview